DCE—MRI对局部进展期乳腺癌新辅助化疗的临床指导价值研究(4)
[15]Ah-See M L，Makris A，Taylor N J，et al.Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2008，14(20)：6580.
[16]Yu HJ，Chen JH，Mehta RS，et al.MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy[J].J Magn Reson Imaging，2007，26(3)： 615-623.
[17]Wasser K，Klein S，Fink C，et al.Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution[J].European Radiology，2003，13(1)：80-87.
[18]李瑞敏，顾雅佳，彭卫军，等.定量动态增强磁共振评估乳腺癌新辅助化疗疗效的应用研究[J].中国癌症杂志，2016，26(7)：623-628.
[19]Wang Y，Huang W，Panicek D M，et al.Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data[J].Magnetic Resonance in Medicine，2008，59(5)：1183-1189.
[20]Ogston K N，Miller I D，Payne S，et al.A new histological grading system to assess response of breast cancers to primary chemotherapy：prognostic significance and survival[J].Breast， 2003，12(5)：320-327.
[21]尹波，刘莉，邹丽萍，等.乳腺癌新辅助化疗前后 DCE-MRI血流动力学与病理学对照[J].放射学实践，2011，26(3)：1062-1066.
收稿日期：2017-10-30；修回日期：2017-11-20
編辑/李桦, http://www.100md.com(屈欣然)
[16]Yu HJ，Chen JH，Mehta RS，et al.MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy[J].J Magn Reson Imaging，2007，26(3)： 615-623.
[17]Wasser K，Klein S，Fink C，et al.Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution[J].European Radiology，2003，13(1)：80-87.
[18]李瑞敏，顾雅佳，彭卫军，等.定量动态增强磁共振评估乳腺癌新辅助化疗疗效的应用研究[J].中国癌症杂志，2016，26(7)：623-628.
[19]Wang Y，Huang W，Panicek D M，et al.Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data[J].Magnetic Resonance in Medicine，2008，59(5)：1183-1189.
[20]Ogston K N，Miller I D，Payne S，et al.A new histological grading system to assess response of breast cancers to primary chemotherapy：prognostic significance and survival[J].Breast， 2003，12(5)：320-327.
[21]尹波，刘莉，邹丽萍，等.乳腺癌新辅助化疗前后 DCE-MRI血流动力学与病理学对照[J].放射学实践，2011，26(3)：1062-1066.
收稿日期：2017-10-30；修回日期：2017-11-20
編辑/李桦, http://www.100md.com(屈欣然)